Renaissance Technologies LLC, under direction of Jim Simons has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $63.1 Billion distributed in 3484 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Palantir Technologies Inc. with a value of $1.43B, Novo Nordisk A S with a value of $975M, United Therapeutics Corp with a value of $772M, Apple Inc. with a value of $763M, and Vertex Pharmaceuticals Inc with a value of $759M.
Examining the 13F form we can see an increase of $6.45B in the current position value, from $56.7B to 63.1B.
Renaissance Technologies LLC is based out at New York, NY
Below you can find more details about Jim Simons portfolio as well as his latest detailed transactions.
Portfolio value
$63.1 Billion
Technology: $12.6 Billion
Healthcare: $10.9 Billion
Consumer Cyclical: $7.84 Billion
Industrials: $5.96 Billion
Financial Services: $5.64 Billion
Consumer Defensive: $4.65 Billion
Communication Services: $3.74 Billion
ETFs: $3.41 Billion
Other: $8.36 Billion
Stock Holdings Table Market Cap. of $50 Millions to $300 Millions
Jim Simons is the founder and chairman of Renaissance Technologies, a successful investment firm that uses quantitative approaches to investing. Simons is known for his expertise in mathematical modeling and has a reputation for being a skilled and successful investor. He has generated strong returns for his clients over the long term.
